Mimedx MDXG
NASDAQ MDXG
$4.59 -0.05 (-1.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Mimedx (MDXG) Liabilities from Discontinued Operations (2022 - 2023)

Updated

Mimedx's Liabilities from Discontinued Operations came in at $1.35 million for Q4 2023, down 8.6% from $1.48 million a year earlier.

Analysis

Mimedx (MDXG) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends

  • Going back by year, Liabilities from Discontinued Operations was $1.48 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Mimedx 668.88 Mn 65.06 Mn 44.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.35 Mn
Dec 31, 2022 1.48 Mn
API Access

Mimedx Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=MDXG&period=max&api_key=YOUR_API_KEY